Jakub Svoboda, MD

Jakub Svoboda, Daniel J Landsburg, James Gerson, Sunita D Nasta, Stefan K Barta, Elise A Chong, Michael Cook, Noelle V Frey, Joanne Shea, Amanda Cervini, Amy Marshall, Megan Four, Megan M Davis, Julie K Jadlowsky, Anne Chew, Edward Pequignot, Vanessa Gonzalez, Julia Han Noll, Luca Paruzzo, Juliana Rojas-Levine, Gabriela Plesa, John Scholler, Donald L Siegel, Bruce L Levine, David L Porter, Saba Ghassemi, Marco Ruella, Andrew Rech, Rachel M Leskowitz, Joseph A Fraietta, Wei-Ting Hwang, Elizabeth Hexner, Stephen J Schuster, Carl H June Enhanced CAR T-cell therapy for lymphoma after previous failure , New England Journal of Medicine, 392(18): 2025,1824-1835

Jakub Svoboda, Steven M Bair, Daniel J Landsburg, Sunita Dwivedy Nasta, Sarah J Nagle, Stefan K Barta, Nadia Khan, Joanne Filicko-O'Hara, Sameh Gaballa, Lauren Strelec, Elise Chong, Sheryl Mitnick, Terease S Waite, Cara King, Hatcher Ballard, Matthew Youngman, James Gerson, John P Plastaras, Amit Maity, Agata M Bogusz, Stacy S Hung, Hisae Nakamura, Reza Nejati, Christian Steidl, Megan Lim, Marco Ruella, Stephen J Schuster Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas , Haematologica, 106(6): 2021,1705 -1713

Schuster SJ, Svoboda J, Chong EA, Nasta SD, Mato AR, Anak Ö, Brogdon JL, Pruteanu-Malinici I, Bhoj V, Landsburg D, Wasik M, Levine BL, Lacey SF, Melenhorst JJ, Porter DL, June CH. Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas , New England Journal of Medicine, 377(26): 2017,2545-2554

Svoboda J, Rheingold SR, Gill SI, Grupp SA, Lacey SF, Kulikovskaya I, Suhoski MM, Melenhorst JJ, Loudon B, Mato AR, Nasta SD, Landsburg DJ, Youngman MR, Levine BL, Porter DL, June CH, Schuster SJ. Non-viral RNA chimeric antigen receptor modified T cells in patients with Hodgkin lymphoma. , Blood, 132(10): 2018,1022-1026

Jackson T. Bowers, Jacob Anna, Steven M. Bair, Kaitlin Annunzio, Narendranath Epperla, Jerrin Joy Pullukkara, Sameh Gaballa, Michael A. Spinner, Shuning Li, Marcus R. Messmer, Joseph Nguyen, Emily C. Ayers, Charlotte B. Wagner, Boyu Hu, Mengyang Di, Scott F. Huntington, Fateeha Furqan, Nirav N. Shah, Christina Chen, Hatcher J. Ballard, Mitchell E. Hughes, Elise A. Chong, Sunita D. Nasta, Stefan K. Barta, Daniel J. Landsburg, Jakub Svoboda Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort , Blood Advances, 7(21): 2023,6630–6638

Ruan J, Martin P, Shah B, Schuster SJ, Smith, SM, Furman RR, Christos P, Rodriguez A, Svoboda J, Lewis J, Katz O, Coleman M, Leonard, JP Lenalidomide Plus Rituximab as Initial Treatment for Mantle Cell Lymphoma. , New England Journal of Medicine, 373(19): 2015,1835-44

Julie K Jadlowsky, Elizabeth O Hexner, Amy Marshall, Stephan A Grupp, Noelle V Frey, James L Riley, Elizabeth Veloso, Holly McConville, Walter Rogal, Cory Czuczman, Wei-Ting Hwang, Yimei Li, Rachel M Leskowitz, Olivia Farrelly, Jayashree Karar, Shannon Christensen, Julie Barber-Rotenberg, Avery Gaymon, Naomi Aronson, Wendy Bernstein, Jan Joseph Melenhorst, Aoife M Roche, John K Everett, Sonja A Zolnoski, Alexander G McFarland, Shantan Reddy, Angelina Petrichenko, Emma J Cook, Carole Lee, Vanessa E Gonzalez, Kathleen Alexander, Irina Kulikovskaya, Ángel Ramírez-Fernández, Janna C Minehart, Marco Ruella, Saar I Gill, Stephen J Schuster, Adam D Cohen, Alfred L Garfall, Payal D Shah, David L Porter, Shannon L Maude, Bruce L Levine, Donald L Siegel, Anne Chew, Stephen McKenna, Lester Lledo, Megan M Davis, Gabriela Plesa, Friederike Herbst, Edward A Stadtmauer, Pablo Tebas, Amanda DiNofia, Andrew Haas, Naomi B Haas, Regina Myers, Donald M O’Rourke, Jakub Svoboda, Janos L Tanyi, Richard Aplenc, Jeffrey M Jacobson, Andrew H Ko, Roger B Cohen, Carl H June, Frederic D Bushman, Joseph A Fraietta Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies , Nature Medicine, 31(4): 2025,1134-1144

G Ghilardi, EA Chong, J Svoboda, P Wohlfarth, SD Nasta, S Williamson, JD Landsburg, JN Gerson, SK Barta, R Pajarillo, J Myers, AI Chen, L Schachter, R Yelton, HJ Ballard, A Hodges Dwinal, S Gier, D Victoriano, E Weber, E Napier, A Garfall, DL Porter, U Jäger, RT Maziarz, M Ruella, SJ Schuster Bendamustine is Safe and Effective for Lymphodepletion Before Tisagenlecleucel in Patients with Refractory or Relapsed Large B-Cell Lymphomas , Annals of Oncology, 33(9): 2022,916-928

Elise A Chong, Cécile Alanio, Jakub Svoboda, Sunita D Nasta, Daniel J Landsburg, Simon F Lacey, Marco Ruella, Siddharth Bhattacharyya, E John Wherry, Stephen J Schuster Pembrolizumab for B-cell lymphomas relapsing after or refractory to CD19-directed CAR T-cell therapy , Blood, 139(7): 2022,1026-1038

P Armand, S Rodig, V Melnichenko, C Thieblemont, K Bouabdallah, G Tumyan, M Özcan, S Portino, L Fogliatto, MD Caballero, J Walewski, Z Gulbas, V Ribrag, B Christian, GF Perini, G Salles, J Svoboda, J Zain, S Patel, PH Chen, AH Ligon, J Ouyang, D Neuberg, R Redd, A Chatterjee, A Balakumaran, R Orlowski, M Shipp, and PL Zinzani Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma , J Clin Oncol., 37(34): 2019,3291-3299